Edition:
United Kingdom

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

5.69USD
24 Sep 2018
Change (% chg)

$-0.01 (-0.18%)
Prev Close
$5.70
Open
$5.68
Day's High
$5.91
Day's Low
$5.65
Volume
92,083
Avg. Vol
166,951
52-wk High
$8.88
52-wk Low
$1.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.068
Mar '18 0.00 -0.050
FY 2017 Dec '17 0.00 -0.077
Sep '17 0.00 -0.027
Jun '17 0.00 -0.040
Mar '17 0.00 -0.028
FY 2016 Dec '16 0.00 -0.029
Sep '16 0.00 -0.034
Jun '16 0.00 -0.077
Mar '16 0.00 -0.045
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 15.59 15.59 15.59 0.65
Earnings (per share)
Quarter Ending Sep-18 1 -0.07 -0.07 -0.07 -0.04
Quarter Ending Dec-18 1 -0.08 -0.08 -0.08 -0.04
Year Ending Dec-18 1 -0.28 -0.28 -0.28 -0.19
Year Ending Dec-19 1 -0.19 -0.19 -0.19 -0.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 0.94 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 6.65 15.51 5.00
Price to Tangible Book (MRQ) 6.65 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 14.25 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.85 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 40.88 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 106.12 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 7.90 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 8.78 37.09 16.85
Interest Coverage (TTM) -691.56 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -7,125.71 -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -7,155.52 -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -8,524.58 -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -8,524.58 -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,030 860,305,024
Net Income/Employee (TTM) -- 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.33 -0.15 11.13
Return on Assets - 5 Yr. Avg. -110.60 3.51 12.40
Return on Investment (TTM) -45.17 1.79 14.61
Return on Investment - 5 Yr. Avg. -119.58 2.56 16.13
Return on Equity (TTM) -62.67 3.28 16.33
Return on Equity - 5 Yr. Avg. -238.20 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 23.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CASI Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.32%
# of Holders: 85
Total Shares Held: 18,459,700
3 Mo. Net Change: 4,868,197
# New Positions: 40
# Closed Positions: 14
# Increased Positions: 65
# Reduced Positions: 18
# Net Buyers: 47
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.